Stryker (SYK) Results Slowing - Jefferies
Get Alerts SYK Hot Sheet
Rating Summary:
25 Buy, 15 Hold, 3 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Jefferies analyst, Raj Denhoy reiterated his Hold rating on shares of Stryker (NYSE: SYK) after SYK’s 2Q results slowed from last Q. Accounting for an extra day, overall organic growth was about 5.6% in 2Q vs. 6.1% last Q—Orthopedics and Neurotech/ Spine both slowed; Medsurg was better. The company cited normal variation but after a good run in shares and a premium valuation, the slowdown will be the story in the Q.
Full year revenue guidance was raised 50 bps on the low end to 6.0-6.5% and EPS was increased by $0.05 on the bottom end to $5.70 to $5.80. 3Q EPS was offered at $1.33 to $1.38 which is modestly lower than the Street’s current $1.41. The lack of outsized leverage to perhaps offset any questions on the topline didn’t materialize and EPS estimates for this year and next are largely unchanged. That said, the price target increases to $120.00 (from $113.00) although no rationale for the increase appeared in the note.
For an analyst ratings summary and ratings history on Stryker click here. For more ratings news on Stryker click here.
Shares of Stryker closed at $122.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- Amphenol (APH) PT Raised to $130 at Evercore ISI, Remains Top Pick
- SL Green Realty (SLG) PT Lowered to $45 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT Change, EarningsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!